| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,290 | 4,916 | 8,758 | 14,035 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 14,290 | 4,916 | 8,758 | 14,035 | | | Operating Expenses | | Research Development | 4,274 | 4,559 | 8,025 | 15,309 | | Selling General and Administrative | 3,443 | 4,783 | 4,428 | 3,234 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,573 | (4,426) | (3,695) | (4,508) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 84 | 156 | 232 | 425 | | Earnings Before Interest And Taxes | 6,658 | (4,270) | (3,463) | (4,083) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 6,658 | (4,270) | (3,463) | (4,083) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,658 | (4,270) | (3,463) | (4,083) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,658 | (4,270) | (3,463) | (4,083) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,658 | ($4,270) | ($3,463) | ($4,083) |
|
0.31% Nasdaq 0.00%
Income Statement
